CARLSBAD, Calif., July 23, 2019 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of InVictus™, a comprehensive spinal fixation platform designed to address a range of pathologies through a minimally invasive (MIS), open, or hybrid surgical approach.
“The InVictus platform incorporates and improves upon the learnings and know-how of a team with unmatched expertise in the field of posterior fixation,” said Pat Miles, Chairman and Chief Executive Officer. “InVictus will be the foundation for ATEC’s thoracolumbar surgical approaches and is a proxy for the sophistication that will be reflected across the entire ATEC portfolio. We are witnessing the unleashing of Spine’s new Organic Innovation Machine.”
With the introduction of the InVictus systems, ATEC has launched seven of twelve products planned for 2019.
InVictus MIS and Open Spinal Fixation Systems
The launch of the InVictus MIS and Open Fixation Systems follow successful evaluations that began in November 2018.
As one of the market’s most comprehensive thoracolumbar fixation platforms, InVictus is designed to provide enhanced strength, adaptability, and predictability compared to previously available fixation systems. InVictus is designed to enable surgeons to customize surgical treatments to meet the clinical needs of each patient. The platform integrates seamlessly with SafeOp neurophysiology to provide objective, actionable, real-time information throughout the procedure for safer and more reproducible spine surgery.
“The level of experience and know-how of the internal design team is evident in every detail as it relates to the implants and instruments,” said Gurvinder S. Deol, M.D. of Wake Orthopaedics in Raleigh, North Carolina. “From the unique InVictus thread pattern to the various reduction options, this sophistication results in excellent intraoperative adaptability, allowing me to tailor my approach to suit each patient. Integrating technologies like SafeOp into the InVictus platform provides real-time neural health feedback, and drives increased safety and better outcomes.”
Timothy R. Kuklo, M.D. of Denver International Spine Center in Colorado added, “My practice consists of adult degenerative pathology to adolescent and adult deformity. Having one reliable system that my team and I can utilize in all cases leads to more predictable outcomes, whether it’s an open, MIS, or hybrid approach.”
Key Features of the InVictus MIS and Open Fixation Systems
ATEC’s InVictus Comprehensive Spinal Fixation Platform has been designed to improve surgical outcomes across a range of degenerative and complex deformity thoracolumbar pathologies, even in the most challenging procedural scenarios. Paired with AlphaInformatiX technologies, InVictus is capable of seamlessly crossing the cervical-thoracic junction and integrating posterior approach systems.
Key features include:
- Biomechanical strength necessary to achieve a solid fusion;
- Unique lock screw design to enhance dependability by reducing head splay and cross threading;
- Wide variety of low-profile implants that accept multiple rod diameters; and
- Ergonomically designed instrumentation, designed to improve surgical predictability and comfort during complex surgeries.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery. ATEC designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company markets its products in the U.S. via independent sales agents and a direct sales force.
Additional information can be found at www.atecspine.com.
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that actual results will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include references to the Company’s planned commercial launches, product introductions and product integration, surgeon and market acceptance of Company products, solutions and platforms, and the Company’s ability to deliver key product features. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to: the uncertainty of success in developing new products or products currently in the Company’s pipeline; failure to achieve acceptance of the Company’s products by the surgeon community; failure to obtain FDA or other regulatory clearance or approval for new products, or unexpected or prolonged delays in the process; continuation of favorable third party reimbursement for procedures performed using the Company’s products; the Company’s ability to compete with other products and with emerging new technologies; product liability exposure; patent infringement claims; and claims related to the Company’s intellectual property. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate,” “look forward” and “anticipate,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. A further list and description of these and other factors, risks and uncertainties can be found in the Company’s most recent annual report, and any subsequent quarterly and current reports, filed with the Securities and Exchange Commission. ATEC disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.